Tirofiban is superior to aspirin in non-obstructive strokes

Published Date: 08 Mar 2023

Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.

Read Full News

Latest News

Pulmonary Embolism Without Chest Pain in a Man

Dyspnea, elevated troponin, and right heart strain can signal pulmonary embolism even when chest pain is absent, making timely imaging essential.

Virtual Hospitalist Programs Growing Across the U.S.

The pandemic delivered unseen benefits. Now virtual hospitalists and patients are reaping the rewards.

Strength Training Linked to Lower CVD Risk in Women

Regular resistance training is associated with a lower risk for major cardiovascular disease in women, especially when it is paired with aerobic activity and less sedentary time.

Penicillin Allergy Labels May Pose Health Risks in Kids

Children with a penicillin allergy label have higher rates of methicillin-resistant Staphylococcus aureus colonization, surgical site infections, and all-cause mortality than those without the label.

GI Symptoms May Predict Cardiac Complications in SSc

In patients with systemic sclerosis, specific gastrointestinal manifestations are linked to distinct cardiac complications, a recent study shows.

Do Women With TBI Receive Appropriate Care?

Female patients with traumatic brain injury were less likely than male patients with TBI to be admitted to specialized trauma centers, according to results of a population-based cohort study.

Todays Updates

FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug

The U.S. Food and Drug Administration has declined to approve Achieve Life Sciences' drug to treat nicotine dependence in adults, ⁠citing unresolved issues found at a...

The New Perfectionism Problem in Medical Training

The profession has always attracted perfectionists. Experts worry a more fear-based version of the trait could affect both doctors and patients.

Rucaparib Delays Next Lines of Therapy in Ovarian Cancer

Rucaparib maintenance delays both first and second subsequent therapies among patients with advanced ovarian cancer.

Todays Updates

FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug

The U.S. Food and Drug Administration has declined to approve Achieve Life Sciences' drug to treat nicotine dependence in adults, ⁠citing unresolved issues found at a...

The New Perfectionism Problem in Medical Training

The profession has always attracted perfectionists. Experts worry a more fear-based version of the trait could affect both doctors and patients.

Rucaparib Delays Next Lines of Therapy in Ovarian Cancer

Rucaparib maintenance delays both first and second subsequent therapies among patients with advanced ovarian cancer.

Latest News

Dyspnea, elevated troponin, and right heart strain can signal pulmonary embolism even when chest pain is absent, making timely imaging essential.

The pandemic delivered unseen benefits. Now virtual hospitalists and patients are reaping the rewards.

Regular resistance training is associated with a lower risk for major cardiovascular disease in women, especially when it is paired with aerobic activity and less sedentary time.

Children with a penicillin allergy label have higher rates of methicillin-resistant Staphylococcus aureus colonization, surgical site infections, and all-cause mortality than those without the label.

In patients with systemic sclerosis, specific gastrointestinal manifestations are linked to distinct cardiac complications, a recent study shows.

Female patients with traumatic brain injury were less likely than male patients with TBI to be admitted to specialized trauma centers, according to results of a population-based cohort study.

News All Time

Quality of Life in Crohn’s Disease: What’s the Best Drug?

Risankizumab is more effective than ustekinumab in achieving sustained clinical improvements in health-related quality of life in patients with Crohn’s disease.

More Evidence Ties Shingles Vax to Lower Dementia Risk

The target trial emulation tracked older adults following a skilled-nursing facility stay.

Nonconventional B-Cell Depletion May Reset Autoimmune Memory

Advanced bispecific T-cell engager therapies achieve deep tissue clearance, driving long-term, drug-free remissions in refractory patients.

Does Distress in Skin Conditions Drive Suicidal Thoughts?

Suicidal ideation increases in patients with skin conditions and is also associated with psychological distress, stigma, and dissatisfaction with appearance, a study shows.

China Steps Up Ebola Monitoring With Revised Prevention Plan

China on Tuesday issued a revised prevention and control plan for the Ebola epidemic, requiring ⁠close contacts of Ebola cases to undergo tracking and quarantined medical...

Kennedy Orders American Exposed to Hantavirus to Stay Quarantined Against Her Will, WSJ Reports

U.S. Health Secretary Robert F. Kennedy Jr. has ordered an American passenger exposed to hantavirus on a cruise ship to remain in quarantine despite medical advice and...

Managing C difficile in IBD: New Guidance From the AGA

The co-occurrence of IBD and Clostridioides difficile poses unique diagnostic and management challenges. A new American Gastroenterological Association statement updates earlier 2017 guidance.

Rare Genetic Disorders in Children: What Raises Suspicion?

Experts outline the clinical features that may signal rare genetic disorders, helping pediatricians identify affected children, and accelerate specialist referrals.

Congo Ebola Response Strained a Month After WHO Declares International Emergency

Health workers battling an Ebola outbreak in eastern Democratic Republic of Congo lack the personnel to identify suspected cases, the ambulances to transport them and even...

Mapping the Clitoris Changes Women's Health

A profound lack of anatomical research into the clitoris has left the medical community blind to the root causes of postpartum nerve damage and chronic pelvic pain.

Baricitinib Exhibits Steroid-Sparing Effect in PMR Trial

A positive new study of the JAK inhibitor in people with newly diagnosed polymyalgia rheumatica adds to data on its efficacy, which has been previously studied in the BACHELOR trial.

Are Difficult Migraine Cases Overtested and Misdiagnosed?

Patients with resistant or refractory migraine undergo repeated diagnostic tests and are often misdiagnosed as having sinus or neck condition.

Adrenaline Underused in Food-Induced Anaphylaxis at Schools

Food-induced anaphylaxis in children in educational settings is commonly triggered by peanuts and is linked to the underuse of adrenaline, a study finds.

Remibrutinib Resolves Chronic Inducible Urticaria

Remibrutinib achieves complete response for the three most common subtypes of chronic inducible urticaria in a phase 3 clinical trial.

Dupilumab Outperforms Omalizumab in High-Biomarker Asthma

Patients with asthma and chronic rhinosinusitis with nasal polyps derive greater benefit from dupilumab as eosinophil and fractional exhaled nitric oxide levels increase.

Study Provides Clues to Paroxetine’s Effects in Rosacea

Paroxetine treatment is associated with clinical improvements and distinct proteomic changes in a small study of women with refractory erythematous rosacea.

Recommended News For You

Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women

AZD0486 Shows Good Efficacy in Relapsed/Refractory Follicular Lymphoma

Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer

Why alarm is easing over a rise in pancreatic cancer among the young

Mezigdomide Combinations Show Promise in Multiple Myeloma

Effects of Recombinant Replacement Therapy Explained in Detailed Regarding Genetic Clotting Disorder.

Durvalumab Wins FDA Approval in Limited-Stage SCLC

Recommended Articles For You

Lymphomatoid Papulosis: What You Need to Know 

Exploring the Latest Advances in PTLD Cancer Treatment 

Metabolic Symbiosis Within the Tumor Niche: Mechanisms, Clinical Implications, and Therapeutic Opportunities 

Neutrophil Profiling and AI Rewrites Cancer Diagnosis 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Only 1 in 4 Eligible Adults Receive Lung Screening

2.

Australian researchers attribute drop in melanoma rates to increasingly diverse population

3.

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL

4.

Finding a clue to the origin of treatment-resistant leukemia in kids

5.

Aster Whitefield Hospital, with 506 beds, opened.

1.

Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology

2.

A Closer Look at MCV Modules: Features, Functions, and Benefits 

3.

Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense

4.

The Significance of APTT Blood Test Results for Detecting Coagulation Disorders

5.

General Practitioners Role in Diagnosing Ovarian Cancer

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

2.

Navigating the Complexities of Ph Negative ALL - Part VII

3.

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

4.

Navigating the Complexities of Ph Negative ALL - Part I

5.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot